SynthesisRenal failure2024

Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis.

Lei Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.